These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9406712)

  • 1. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
    DeNardo GL; Kukis DL; DeNardo SJ; Shen S; Mausner LF; O'Donnell RT; Lamborn KR; Meyers FJ; Srivastava SC; Miers LA
    Cancer; 1997 Dec; 80(12 Suppl):2576-82. PubMed ID: 9406712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-related gene and protein expression in human lymphoma xenografts (Raji) after low dose rate radiation using 67Cu-2IT-BAT-Lym-1 radioimmunotherapy.
    Kroger LA; DeNardo GL; Gumerlock PH; Xiong CY; Winthrop MD; Shi XB; Mack PC; Leshchinsky T; DeNardo SJ
    Cancer Biother Radiopharm; 2001 Jun; 16(3):213-25. PubMed ID: 11471486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).
    DeNardo GL; Kukis DL; Shen S; Mausner LF; Meares CF; Srivastava SC; Miers LA; DeNardo SJ
    Clin Cancer Res; 1997 Jan; 3(1):71-9. PubMed ID: 9815540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
    DeNardo GL; Kukis DL; Shen S; DeNardo DA; Meares CF; DeNardo SJ
    Clin Cancer Res; 1999 Mar; 5(3):533-41. PubMed ID: 10100704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts.
    O'Donnell RT; DeNardo SJ; Miers LA; Kukis DL; Mirick GR; Kroger LA; DeNardo GL
    Cancer Biother Radiopharm; 1998 Oct; 13(5):351-61. PubMed ID: 10851425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.
    Denardo GL; Denardo SJ; Kukis DL; O'Donnell RT; Shen S; Goldstein DS; Kroger LA; Salako Q; Denardo DA; Mirick GR; Mausner LF; Srivastava SC; Meares CF
    Anticancer Res; 1998; 18(4B):2779-88. PubMed ID: 9713461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
    DeNardo SJ; DeNardo GL; Kukis DL; Shen S; Kroger LA; DeNardo DA; Goldstein DS; Mirick GR; Salako Q; Mausner LF; Srivastava SC; Meares CF
    J Nucl Med; 1999 Feb; 40(2):302-10. PubMed ID: 10025839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.
    O'Donnell RT; DeNardo GL; Kukis DL; Lamborn KR; Shen S; Yuan A; Goldstein DS; Mirick GR; DeNardo SJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3330s-3336s. PubMed ID: 10541382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model.
    Kroger LA; DeNardo SJ; DeNardo GL; Xiong CY; Winthrop MD; Gumerlock PH
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3010s-3014s. PubMed ID: 10541336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
    DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
    Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.
    O'Donnell RT; DeNardo GL; Kukis DL; Lamborn KR; Shen S; Yuan A; Goldstein DS; Carr CE; Mirick GR; DeNardo SJ
    J Nucl Med; 1999 Dec; 40(12):2014-20. PubMed ID: 10616879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.
    Mirick GR; O'Donnell RT; DeNardo SJ; Shen S; Meares CF; DeNardo GL
    Nucl Med Biol; 1999 Oct; 26(7):841-5. PubMed ID: 10628566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to macrocycles in lymphoma.
    DeNardo GL; Mirick GR; Kroger LA; O'Donnell RT; Meares CF; DeNardo SJ
    J Nucl Med; 1996 Mar; 37(3):451-6. PubMed ID: 8772643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu.
    Connett JM; Anderson CJ; Guo LW; Schwarz SW; Zinn KR; Rogers BE; Siegel BA; Philpott GW; Welch MJ
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6814-8. PubMed ID: 8692901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
    DeNardo GL; DeNardo SJ; O'Donnell RT; Kroger LA; Kukis DL; Meares CF; Goldstein DS; Shen S
    Clin Lymphoma; 2000 Sep; 1(2):118-26. PubMed ID: 11707820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
    Kukis DL; DeNardo GL; DeNardo SJ; Mirick GR; Miers LA; Greiner DP; Meares CF
    Cancer Res; 1995 Feb; 55(4):878-84. PubMed ID: 7850803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates.
    Kukis DL; Diril H; Greiner DP; DeNardo SJ; DeNardo GL; Salako QA; Meares CF
    Cancer; 1994 Feb; 73(3 Suppl):779-86. PubMed ID: 8306260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary cell kinetics model of thrombocytopenia after radioimmunotherapy.
    Shen S; DeNardo GL; Jones TD; Wilder RB; O'Donnell RT; DeNardo SJ
    J Nucl Med; 1998 Jul; 39(7):1223-9. PubMed ID: 9669399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
    O'Donnell RT; Shen S; Denardo SJ; Wun T; Kukis DL; Goldstein DS; Denardo GL
    Anticancer Res; 2000; 20(5C):3647-55. PubMed ID: 11268433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for enhancement of radioimmunotherapy.
    DeNardo G; DeNardo S; Kukis D; Diril H; Suey C; Meares C
    Int J Rad Appl Instrum B; 1991; 18(6):633-40. PubMed ID: 1743986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.